drugset / Trial / NCT02398591
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of three dosages (250, 500, and 1000 milligram \[mg\], or maximum tolerated dose \[MTD\]) of JNJ 53718678 when administered as single dose in fasting conditions in healthy Japanese adult participants in 3 cohorts.
Timeline
- Start
- 2015-04-01
- Primary completion
- 2015-07-15
- Completion
- 2015-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rilematovir | Other / unclassified | 250 mg | Oral |
| Subject | Rilematovir | Other / unclassified | 500 mg | Oral |
| Subject | Rilematovir | Other / unclassified | 1000 mg | Oral |
Indications
No indication recorded.